BlackSky Technology Inc. (BKSY)
CIK 1753539 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 40.9M shares as of Aug 3, 2026 (10-Q). Share count fell from 148.9M to 30.8M between Aug 6, 2024 and Nov 5, 2024, a pattern consistent with a reverse split (roughly 1-for-5); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Self-funding
profitable · generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Public Placement Warrants | 2.0M | $92 | — | FV $791,000 |
| Private Warrants Tranche Three | 1.4M | $17.61 | — | FV $31.7M |
| Private Warrants Tranche One | 520,000 | $92 | — | FV $208,000 |
| Private Warrants Tranche Two | 520,000 | $160 | — | FV $21,000 |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 2.0M underlying shares, as reported Mar 31, 2025 (10-Q).
Reported exercise price: $0.11 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $47.4M as of Jun 30, 2021.
Rough fully diluted estimate: 43.0M = 40.9M O/S + 2.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Convertible Notes Due August 2033 | $185.0M | — | $36.78 | 8.25% | ~5.0M sh |
If every note above converted at its tagged price: ~5.0M new shares on 40.9M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 40.9M | Aug 3, 2026 |
| + Public Placement Warrants (if exercised) | 2.0M | Jun 30, 2026 |
| + Private Warrants Tranche Three (if exercised) | 1.4M | Jun 30, 2026 |
| + Private Warrants Tranche One (if exercised) | 520,000 | Jun 30, 2026 |
| + Private Warrants Tranche Two (if exercised) | 520,000 | Jun 30, 2026 |
| + Convertible Notes Due August 2033 (if fully converted) | 5.0M | Jul 31, 2025 |
| Fully diluted estimate | 50.4M | +23.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $250.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 2 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full BKSY workspace